Sepsis-like cytokine release syndrome after application of tebentafusp in metastasized uveal melanoma

J Eur Acad Dermatol Venereol. 2024 Jun;38(6):e473-e475. doi: 10.1111/jdv.19660. Epub 2023 Dec 7.

Authors

Glenn Geidel^{1

2}, Finn Abeck¹, Inga Hansen¹, Julian Kött^{1

2}, Isabel Heidrich^{1

2}, Alessandra Rünger^{1

2}, Lina Hildebrandt¹, Christoffer Gebhardt^{1

2}

Affiliations

¹ Department of Dermatology and Venereology, University Skin Cancer Center Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
² Fleur Hiege Center for Skin Cancer Research, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

PMID: 38059699
DOI: 10.1111/jdv.19660

No abstract available

Publication types

Letter
Case Reports

MeSH terms

Cytokine Release Syndrome* / etiology
Female
Humans
Male
Melanoma* / pathology
Melanoma* / secondary
Middle Aged
Sepsis / complications
Uveal Neoplasms* / pathology
Uveal Neoplasms* / secondary

Supplementary concepts

Uveal melanoma